Robert Janssen

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Josue Antonio Estrada, Chien-Yu Cheng, Shin-Yen Ku, Hui-Chun Hu, Hsiu-Wen Yeh, Yi-Chun Lin, Cheng-Pin Chen, Shu-Hsing Cheng, Robert Janssen, I-Feng Lin
An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901. Vaccines 10 (5) (2022)
Ezra E W Cohen, Lisle Nabell, Deborah J Wong, Terry A Day, Gregory A Daniels, Mohammed Milhem, Sanjeev Deva, Michael B Jameson, Orlando Guntinas-Lichius, Mohammed Almubarak, Matthew Strother, Eric D Whitman, Michael Chisamore, Cynthia Obiozor, Teresa Bagulho, Jose Gomez-Romo, Cristiana Guiducci, Robert Janssen, Erick Gamelin, Alain Patrick Algazi
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (6) (2022)
Edward B Garon, Alexander I Spira, Melissa Johnson, Lyudmila Bazhenova, Joseph Leach, Amy L Cummings, Albert Candia, Robert L Coffman, Mary J Janatpour, Robert Janssen, Erick Gamelin, Laura Q M Chow
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)